| Literature DB >> 26888332 |
Anastasia Georgantzopoulou1,2, Tommaso Serchi3, Sébastien Cambier4, Céline C Leclercq5, Jenny Renaut6, Jia Shao7,8, Marcin Kruszewski9,10, Esther Lentzen11, Patrick Grysan12, Santhana Eswara13, Jean-Nicolas Audinot14, Servane Contal15, Johanna Ziebel16, Cédric Guignard17, Lucien Hoffmann18, AlberTinka J Murk19,20, Arno C Gutleb21.
Abstract
BACKGROUND: The increased incorporation of silver nanoparticles (Ag NPs) into consumer products makes the characterization of potential risk for humans and other organisms essential. The oral route is an important uptake route for NPs, therefore the study of the gastrointestinal tract in respect to NP uptake and toxicity is very timely. The aim of the present study was to evaluate the effects of Ag NPs and ions on a Caco-2/TC7:HT29-MTX intestinal co-culture model with mucus secretion, which constitutes an important protective barrier to exogenous agents in vivo and may strongly influence particle uptake.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26888332 PMCID: PMC4756536 DOI: 10.1186/s12989-016-0117-9
Source DB: PubMed Journal: Part Fibre Toxicol ISSN: 1743-8977 Impact factor: 9.400
Fig. 1Particle characterization. Transmission electron microscopy (TEM) images of (a) Ag 20 nm and (b) Ag 200 mn. (c) Size distribution of the particles Ag 20 nm and Ag 200 nm in the cell culture medium with 10 % FBS at the highest exposure concentration used (100 mg/L). Scale bar is 100 nm
Overview of particle characteristics. Main characteristics of the Ag particles studied and the ions released in cell culture medium containing 10 % FBS after 24 h at the highest concentration at which the cells were exposed to (100 mg/L)
| Particles | Primary size (nm) | Hydrodynamic diameter (nm) | Z potential (mV) | Soluble Ag released (μg/L) |
|---|---|---|---|---|
| Ag 20 nm | 20 | 129 | -12.8 | <10 (0.01 %) |
| Ag 200 nm | 200 | 308 | -13.9 | < 10 (0.01 %) |
The Z potential in MilliQ water was -14.2 and -11 for Ag 20 and 200 nm, respectively while the values in DMEM without phenol red and FBS were +3.5 (Ag 20 nm) and +0.5 mV (Ag 200 nm)
Fig. 2Effects on metabolic activity. Effects of (a) AgNO3 and (b) Ag 20 and 200 nm on the viability (determined as metabolic activity) of Caco-2/TC7 and HT29-MTX cells in co-culture at a 90:10 ratio. After 14 days in culture the cells were exposed for 24 h. Error bars represent the mean ± SD of 3 independent experiments performed in triplicate. * indicates significant differences of the treatments from the respective untreated controls (P < 0.05)
Fig. 3Intracellular reactive oxygen species formation. Effect of (a) H2O2 (positive control), (b) AgNO3 and (c) Ag 20 and 200 nm particles on the reactive oxygen species formation. After 14 days in culture Caco-2/TC7, HT29-MTX and the 90:10 co-culture were exposed for 2 h. Error bars represent the mean ± SD of 3 independent experiments performed in triplicate. Significant differences from respective untreated controls are marked with asterisks (* for P < 0.05)
Fig. 4IL-8 release. IL-8 release in exposed Caco-2/TC7, HT29-MTX cells and their co-culture to (a) AgNO3 and (b) Ag 20 and 200 nm particles. Differentiated cells (after 14 days of culture) were exposed for 24 h. Error bars represent the mean ± SD of 3 independent experiments performed in duplicate. Significant differences from respective untreated controls are marked with asterisks (* for P < 0.05)
Fig. 5Elemental distribution of 31P, 34S and 107Ag (green) in 300 nm cuts. Caco-2/TC7:HT29-MTX cells in 90:10 co-culture were exposed to (b) Ag 20 nm (c) Ag 200 nm and (d) AgNO3 for 24 h while (a) represents the untreated control cells. Scale bar is 5 μm. The color scales indicated are for P and S images. For Ag images, the secondary ion intensity is expressed in green scale
Proteins with altered abundance. The cells in co-culture were exposed to the non-toxic concentration of 1 mg/L of Ag 20 nm NPs, Ag 200 nm NPs or AgNO3 a)
| Spot N° | Protein name | UniProt Ac. N° | UniProt ID | NCBI GI | Cov. % | MOWSE Score | p-value | Queries matched | Mr (Da) | pI (pH) | AgNO3 vs Control | Ag 20nm vs Control | Ag 200nm vs Control | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fold Change | t-test | Fold Change | t-test | Fold Change | t-test | |||||||||||
| Cytoskeleton-associated proteins | ||||||||||||||||
| 260 | villin-1 | P09327 | VILI_HUMAN | 194394237 | 40% | 153 | 2.7e-010 | 40 | 93093 | 5.99 | −1.13 | 0.351 | −1.03 | 0.792 |
|
|
| 701 | keratin, type II cytoskeletal 8 | P05787 | K2C8_HUMAN | 4504919 | 64% | 274 | 2.2e-022 | 38 | 53671 | 5.52 | −1.29 | 0.451 |
|
| −1.97 | 0.12 |
| 800 | keratin, type II cytoskeletal 8 | P05787 | K2C8_HUMAN | 4504919 | 67% | 345 | 1.7e-029 | 43 | 53671 | 5.52 | 1.13 | 0.468 |
|
| 1.16 | 0.18 |
| 1083 | keratin, type II cytoskeletal 8 | P05787 | K2C8_HUMAN | 4504919 | 59% | 412 | 3.4e-036 | 44 | 53671 | 5.52 |
|
|
|
| 1.1 | 0.598 |
| 841 | cytokeratin 18 (424 AA) | P05783 | K1C18_HUMAN | 30311 | 77% | 387 | 1.1e-033 | 46 | 47305 | 5.27 | 1.1 | 0.502 |
|
| 1.02 | 0.802 |
| 263 | gelsolin isoform a precursor | B7Z9A0 | B7Z9A0_HUMAN | 221045118 | 35% | 130 | 5.4e-008 | 34 | 83451 | 5.58 | −1.1 | 0.751 |
|
| 1.33 | 0.218 |
| 984 | actin, cytoplasmic 1 | P60709 | ACTB_HUMAN | 14250401 | 72% | 527 | 1.1e-047 | 38 | 41321 | 5.56 | −1.1 | 0.114 |
|
| −1.05 | 0.282 |
| 993 | actin, cytoplasmic 1 | Q53G99 | Q53G99_HUMAN | 62897625 | 85% | 642 | 3.4e-059 | 42 | 42080 | 5.37 | −1.22 | 0.083 |
|
| −1.1 | 0.319 |
| 683 | tubulin alpha-1B chain | P68363 | TBA1B_HUMAN | 119578453 | 60% | 317 | 1.1e-026 | 30 | 46797 | 4.96 |
|
| −1.55 | 0.077 | 1.07 | 0.815 |
| 713 | tubulin, beta 2C, isoform CRA_b | Q8N6N5 | Q8N6N5_HUMAN | 119608775 | 55% | 272 | 3.4e-022 | 38 | 49250 | 4.88 |
|
| −1.22 | 0.331 | 1.32 | 0.267 |
| 538 | dihydropyrimidinase-related protein 2 | Q16555 | DPYL2_HUMAN | 4503377 | 62% | 347 | 1.1e-029 | 40 | 62711 | 5.95 |
|
| 1.44 | 0.08 | 1.44 | 0.117 |
| Oxidative stress-associated proteins | ||||||||||||||||
| 1492 | peroxiredoxin-6 | P30041 | PRDX6_HUMAN | 4758638 | 89% | 718 | 8.6e-067 | 46 | 25133 | 6.00 |
|
|
|
|
|
|
| 627 | protein disulfide-isomerase A3 | P30101 | PDIA3_HUMAN | 220702506 | 58% | 271 | 4.3e-022 | 38 | 55328 | 5.61 | 1.1 | 0.383 |
|
|
|
|
| 629 | protein disulfide-isomerase A3 | P30101 | PDIA3_HUMAN | 220702506 | 64% | 795 | 1.7e-074 | 43 | 54541 | 5.61 | 1.34 | 0.18 |
|
| 1.42 | 0.106 |
| 635 | protein disulfide-isomerase A3 | P30101 | PDIA3_HUMAN | 220702506 | 63% | 645 | 1.7e-059 | 44 | 54541 | 5.61 | 1.32 | 0.146 |
|
| 1.22 | 0.2 |
| 655 | protein disulfide isomerase family A, member 3, isoform CRA_a | B3KQT9 | B3KQT9_HUMAN | 119597640 | 40% | 81 | 0.0039 | 21 | 54454 | 6.78 |
|
| 1.1 | 0.247 | −1.06 | 0.514 |
| 765 | protein disulfide-isomerase A6 | Q15084 | PDIA6_HUMAN | 1710248 | 63% | 419 | 6.8e-037 | 38 | 46512 | 4.95 | 1.32 | 0.118 |
|
| −1.11 | 0.618 |
| 769 | protein disulfide-isomerase A6 | Q15084 | PDIA6_HUMAN | 1710248 | 63% | 467 | 1.1e-041 | 43 | 46512 | 4.95 | 1.25 | 0.104 |
|
| 1.05 | 0.757 |
| 767 | glutathione synthetase | P48637 | GSHB_HUMAN | 4504169 | 70% | 580 | 5.4e-053 | 50 | 52523 | 5.67 | −1.08 | 0.367 |
|
| 1.01 | 0.79 |
| Apoptosis-associated proteins | ||||||||||||||||
| 1203 | annexin A4 | P09525 | ANXA4_HUMAN | 1703319 | 73% | 453 | 2.7e-040 | 39 | 36088 | 5.84 | −1.27 | 0.021 |
|
| −1.04 | 0.703 |
| 1208 | annexin A4 | P09525 | ANXA4_HUMAN | 1703319 | 69% | 346 | 1.4e-029 | 37 | 36088 | 5.84 | −1.16 | 0.434 | −1.1 | 0.611 |
|
|
| 1226 | annexin A4 | P09525 | ANXA4_HUMAN | 1703319 | 73% | 731 | 4.3e-068 | 42 | 36088 | 5.84 | −1.24 | 0.119 |
|
| −1.06 | 0.676 |
| 1769 | histidine triad nucleotide-binding protein 1 | P49773 | HINT1_HUMAN | 227968190 | 94% | 105 | 1.7e-005 | 18 | 13887 | 6.24 | 1.16 | 0.224 |
|
| 1.24 | 0.037 |
| 1773 | programmed cell death protein 5 | O14737 | PDCD5_HUMAN | 159163907 | 84% | 217 | 1.1e-016 | 22 | 12911 | 9.85 |
|
| 1.03 | 0.896 | −1.45 | 0.115 |
| Stress-associated proteins | ||||||||||||||||
| 408 | heat shock cognate 71 kDa protein isoform 2 | Q53HF2 | Q53HF2_HUMAN | 24234686 | 57% | 419 | 6.8e-037 | 39 | 53598 | 5.62 | −1.03 | 0.896 |
|
| −1.04 | 0.845 |
| 414 | heat shock 70 kDa protein 1A/1B | P08107 | HSP71_HUMAN | 147744565 | 62% | 248 | 8.6e-020 | 33 | 70294 | 5.48 |
|
|
|
| 1.1 | 0.493 |
| 429 | heat shock 70 kDa protein 1A/1B | P08107 | HSP71_HUMAN | 147744565 | 56% | 515 | 1.7e-046 | 45 | 70294 | 5.48 |
|
|
|
| 1.28 | 0.269 |
| 438 | heat shock 70 kDa protein 1A/1B | P08107 | HSP71_HUMAN | 147744565 | 51% | 203 | 2.7e-015 | 31 | 70294 | 5.48 |
|
|
|
| 1.04 | 0.913 |
| 573 | 60 kDa heat shock protein, mitochondrial | P10809 | CH60_HUMAN | 31542947 | 53% | 357 | 1.1e-030 | 43 | 61187 | 5.70 | −1.03 | 0.884 |
|
| −1.22 | 0.44 |
| 576 | 60 kDa heat shock protein, mitochondrial | P10809 | CH60_HUMAN | 31542947 | 45% | 138 | 8.6e-009 | 30 | 61187 | 5.70 | −1 | 0.86 |
|
| −1.15 | 0.356 |
| 577 | 60 kDa heat shock protein, mitochondrial | P10809 | CH60_HUMAN | 31542947 | 57% | 641 | 4.3e-059 | 47 | 61187 | 5.70 | −1.04 | 0.889 |
|
| −1.21 | 0.577 |
| 578 | 60 kDa heat shock protein, mitochondrial | P10809 | CH60_HUMAN | 31542947 | 72% | 684 | 2.2e-063 | 49 | 61187 | 5.70 | −1.04 | 0.869 |
|
| −1.26 | 0.469 |
| 473 | stress-induced-phosphoprotein 1 | P31948 | STIP1_HUMAN | 5803181 | 54% | 131 | 4.3e-008 | 29 | 68721 | 7.81 | 1.05 | 0.57 |
|
|
|
|
| 479 | stress-induced-phosphoprotein 1 | P31948 | STIP1_HUMAN | 5803181 | 58% | 122 | 3.4e-007 | 28 | 68721 | 7.81 | 1.08 | 0.404 |
|
| 1.29 | 0.032 |
| Metabolism-associated proteins | ||||||||||||||||
| 625 | liver carboxylesterase 1 | P23141 | EST1_HUMAN | 30749518 | 45% | 133 | 2.7e-008 | 38 | 60692 | 6.06 | −1.06 | 0.869 |
|
| −1.18 | 0.488 |
| 631 | liver carboxylesterase 1 | P23141 | EST1_HUMAN | 30749518 | 51% | 109 | 6.8e-006 | 31 | 60692 | 6.06 | −1.13 | 0.732 |
|
| −1.48 | 0.191 |
| 1543 | glutathione S-transferase P | P09211 | GSTP1_HUMAN | 4504183 | 75% | 716 | 1.4e-066 | 29 | 23569 | 5.43 | −1.14 | 0.435 |
|
| −1.29 | 0.19 |
| 1569 | glutathione S-transferase P | P09211 | GSTP1_HUMAN | 4504183 | 75% | 681 | 4.3e-063 | 26 | 23569 | 5.43 | −1.03 | 0.791 |
|
| −1.17 | 0.266 |
| 1866 | fatty acid binding protein | P07148 | FABPL_HUMAN | 182356 | 91% | 408 | 8.6e-036 | 21 | 14226 | 6.60 | 1.26 | 0.195 |
|
| −1.07 | 0.706 |
| 1177 | inorganic pyrophosphatase | Q15181 | IPYR_HUMAN | 11056044 | 77% | 234 | 2.2e-018 | 29 | 33095 | 5.54 | −1.16 | 0.332 |
|
| 1.2 | 0.366 |
| 1199 | inorganic pyrophosphatase | Q15181 | IPYR_HUMAN | 11056044 | 68% | 169 | 6.8e-012 | 25 | 33095 | 5.54 | −1.03 | 0.975 |
|
| 1.26 | 0.309 |
| 1045 | sialic acid synthase | Q9NR45 | SIAS_HUMAN | 12056473 | 76% | 397 | 1.1e-034 | 39 | 40738 | 6.29 | −1.15 | 0.548 |
|
| 1.37 | 0.109 |
| 1133 | pyridoxal kinase | O00764 | PDXK_HUMAN | 119629883 | 45% | 123 | 2.7e-007 | 24 | 42931 | 7.59 | −1.06 | 0.702 |
|
| 1.01 | 0.988 |
| 1320 | purine nucleoside phosphorylase | P00491 | PNPH_HUMAN | 157168362 | 73% | 244 | 2.2e-019 | 29 | 32758 | 6.71 | −1.25 | 0.249 |
|
| −1.18 | 0.405 |
| 941 | aspartate aminotransferase, cytoplasmic | P17174 | AATC_HUMAN | 4504067 | 72% | 298 | 8.6e-025 | 39 | 46447 | 6.52 |
|
| 1.03 | 0.966 | 1.11 | 0.632 |
| 1938 | polyubiquitin-C | F5H7Y5 | F5H7Y5_HUMAN | 228311825 | 80% | 556 | 1.4e-050 | 24 | 17081 | 6.22 |
|
| 1.09 | 0.514 | −1.19 | 0.268 |
| 185 | elongation factor 2 | P13639 | EF2_HUMAN | 4503483 | 37% | 197 | 1.1e-014 | 38 | 96246 | 6.41 | 1.24 | 0.164 |
|
| 1.15 | 0.595 |
| 200 | elongation factor 2 | P13639 | EF2_HUMAN | 4503483 | 46% | 258 | 8.6e-021 | 45 | 96246 | 6.41 | −1.15 | 0.164 |
|
| 1.21 | 0.646 |
| 1734 | peptidyl-prolyl cis-trans isomerase A | P62937 | PPIA_HUMAN | 1633054 | 93% | 443 | 2.7e-039 | 23 | 18098 | 7.82 |
|
|
|
| −1.27 | 0.125 |
| 994 | leukocyte elastase inhibitor | P30740 | ILEU_HUMAN | 13489087 | 56% | 563 | 2.7e-051 | 39 | 42829 | 5.90 |
|
|
|
| −1.25 | 0.147 |
| 1007 | leukocyte elastase inhibitor | P30740 | ILEU_HUMAN | 13489087 | 52% | 266 | 1.4e-021 | 27 | 42829 | 5.90 |
|
|
|
| −1.39 | 0.151 |
| 1020 | leukocyte elastase inhibitor | P30740 | ILEU_HUMAN | 13489087 | 56% | 662 | 3.4e-061 | 39 | 42829 | 5.90 | −1.22 | 0.024 |
|
| 1.11 | 0.021 |
| 703 | retinal dehydrogenase 1 | P00352 | AL1A1_HUMAN | 21361176 | 52% | 318 | 8.6e-027 | 45 | 55454 | 6.30 | −1.28 | 0.064 |
|
| 1.19 | 0.18 |
| 815 | alpha-enolase | P06733 | ENOA_HUMAN | 203282367 | 78% | 531 | 4.3e-048 | 48 | 47350 | 6.99 | 1.07 | 0.614 |
|
| 1.12 | 0.479 |
| 816 | alpha-enolase | P06733 | ENOA_HUMAN | 203282367 | 80% | 383 | 2.7e-033 | 45 | 47350 | 6.99 | −1.03 | 0.803 |
|
| 1.05 | 0.737 |
| 1426 | triosephosphate isomerase isoform 1 | P60174 | TPIS_HUMAN | 4507645 | 97% | 631 | 4.3e-058 | 51 | 26938 | 6.45 | 1.13 | 0.515 |
|
| 1.09 | 0.582 |
| 1443 | triosephosphate isomerase isoform 1 | P60174 | TPIS_HUMAN | 4507645 | 94% | 830 | 5.4e-078 | 53 | 26938 | 6.45 | −1.02 | 0.946 |
|
| 1.18 | 0.501 |
| 1461 | triosephosphate isomerase isoform 1 | P60174 | TPIS_HUMAN | 66360365 | 55% | 171 | 4.3e-012 | 26 | 26938 | 6.45 |
|
| −1.08 | 0.667 | −1.13 | 0.494 |
| 1008 | fructose-bisphosphate aldolase C | P09972 | ALDOC_HUMAN | 61680382 | 61% | 138 | 8.6e-009 | 23 | 37940 | 6.67 | −1.23 | 0.047 | −1.07 | 0.334 |
|
|
| Others | ||||||||||||||||
| 1357 | chloride intracellular channel protein 1 | O00299 | CLIC1_HUMAN | 14251209 | 81% | 322 | 3.4e-027 | 31 | 27248 | 5.09 | 1.2 | 0.107 |
|
| −1.2 | 0.064 |
| 1370 | chloride intracellular channel protein 1 | O00299 | CLIC1_HUMAN | 14251209 | 75% | 506 | 1.4e-045 | 38 | 27248 | 5.09 | −1.04 | 0.808 |
|
| −1.22 | 0.213 |
a)The spot number; protein name; UniProt accession number; UniProt ID; NCBI accession number; sequence coverage; MOWSE score; p-value relative to the MASCOT identification; number of queries matched; theoretical molecular weight (expressed in Da) and isoelectric point (expressed in pH units); the fold change and relative t-test value for co-cultures treated with AgNO3, Ag 20 nm NPs and Ag 200 nm NPs, respectively, are reported for each protein. Italics = protein is more abundant; Bold = protein is less abundant.
Fig. 6Principal component analysis of differentially expressed proteins. Caco-2/TC7:HT29-MTX cells in 90:10 co-culture were exposed to 1 mg/L of Ag 20 nm, Ag 200 nm or AgNO3 for 24 h
Fig. 7A representative 2D-DIGE gel. Caco-2/TC7:HT29-MTX cells in 90:10 co-culture were exposed to 1 mg/L of Ag NPs 20 nm, 200 nm or AgNO3 for 24 h prior to protein extraction. Cytosolic proteins were separated in first dimension on 24 cm strips, pH 3–10 non-linear and in second dimension on a 12.5 % polyacrylamide precast gel. Yellow dots indicate picking location on the gels. For each spot the relative spot number is reported